10.13.26 -- Bravo, FDA For Retiring 'Animal Testing' In Favor Of 'Nonclinical'

Discover an innovative approach to drug conjugation that expands the range of molecules suitable for targeted therapies while preserving their biological activity and enabling controlled drug release.

Examine a streamlined dPCR-based workflow for precise lentiviral vector quantification to support safer, more consistent cell and gene therapies through accurate genome titer, VCN, and RCL assessment.

A comprehensive approach to evaluating drug molecules for the selection of a lead solid form and formulation can significantly accelerate development timelines and limit risks in later development.

Capturing dynamic biomolecular motion remains crucial for research. EPR spectroscopy delivers ensemble distance distributions to resolve flexible states in complex protein systems.

DELs can screen billions of compounds, but library quality determines meaningful results. See how thoughtful design shapes early decisions that influence which drug candidates move forward.

Uncover the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how leveraging ASD formulation can help create more effective, patient-friendly drug products.

The increasing complexity of the drugs currently in clinical development has created mounting pressure for companies hoping to surmount the myriad challenges that typify these therapeutic modalities.